Company Profile
U-Care Medical is a tech-based start-up, spin-off of Polytechnic of Turin. U-Care Medical was born in 2021 with the aim of bringing to the market the patented results of 3 years of scientific research carried out by the co-founders within the Polytechnic of Turin.
Our core product is a SaaS AI-based software platform for the personalized and preventive management of kidney diseases within the intensive care units. By integrating with the Electronic Health Record systems of ICU, we leverage the vast clinical data pool to provide data-driven and real-time predictive alerts to clinicians:
“We empower clinicians to make personalized and faster decisions, via proactive kidney care that saves lives”
Value
At U-Care Medical, We believe that AI should be used for socially beneficial purposes and always remain under meaningful human control. Understanding what this means in practice is essential. Humans are leaders of every technological change, and develop disruptive human-centric solutions at the service of society. We embrace scientific values like transparency, freedom of thought, and the equality of access, and we deeply respect the independence and academic integrity of our researchers and partners. We trust AI-technology and data-science have the potential to revolutionize medicine.
Milestones
2019
Jan 2020
Jun 2020
Jul 2020
Dec 2020
Apr 2021
May 2021
Jun 2021
Sep 2021
Nov 2021
Jan 2022
Jul 2022
- Collaboration Started between Politecnico di Torino e l’Azienda Ospedaliera di Terni
- First Patent Filed & Proof Of Concept from VV3T
- Winner of StartCup Piemonte & Valle D’Aosta: A Regional Entrepreneurial Projects Competition
- Jul 2020 - AKIRA Software First Clinical Validation
- Winner of PNI LifeScience: the most important startup competition in Italy
- Published PoC results on Journal of Nephrology
- Winner of Arkathon Program, a leading Startup Program in Swizerland
- Startup incorporated & Incubation at I3P
- Pre-Seed Deal & First Commercial Agreement Signed
- AKIRA Software Validation on 300k patients from 100+ US and EU
- Integration Pilot in multiple European ICUs
- Granted "Smart & Start" public funding by Invitalia
